Skip to main content
Medivir logo

Medivir — Investor Relations & Filings

Ticker · MVIR ISIN · SE0020181014 LEI · 549300VWDGUX0WMJ1T79 ST Manufacturing
Open in API
Filings indexed 965 across all filing types
Latest filing 2015-02-18 Major Shareholding Noti…
Country SE Sweden
Listing ST MVIR

About Medivir

https://www.medivir.com/

Medivir is a pharmaceutical company specializing in the discovery and clinical development of innovative drugs for cancer. The company focuses on oncology areas with high unmet medical needs, aiming to provide transformative treatments for patients with limited therapeutic options. Its research and development strategy is based on extensive expertise in drug design, particularly targeting enzymes such as proteases and polymerases, and includes the use of a proprietary prodrug platform. Medivir actively pursues collaborations with academic and industrial partners to advance its pipeline from research through to commercialization.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2015
Major Shareholding Notification Classification · 99% confidence The document explicitly details a change in shareholding for a specific holder ('AFA Försäkring') involving a reduction in the number of shares held, along with the resulting percentage of voting rights. The section header 'Reason for major shareholding notification Sell' directly indicates this is a notification regarding a significant change in ownership. This aligns perfectly with the definition of Major Shareholding Notification (MRQ). The document length is short (2015 chars), but the content is the notification itself, not an announcement of a separate report.
2015-02-18 English
Medivir’s Nomination Committee proposes new Board of Directors ahead of 2015 AGM
Board/Management Information Classification · 99% confidence The document explicitly discusses the 'Nomination Committee's proposal for a new Board of Directors' to be submitted to the '2015 Annual General Meeting (AGM)'. This content directly relates to the composition of the board and management structure, which falls under Board/Management Information (MANG). While it is related to the AGM, the core subject is the proposed board changes, not the voting results (DVA) or general AGM materials (AGM-R). It is not a formal regulatory filing like a 10-K or ER, nor is it a general announcement of a report (RPA).
2015-02-18 English
Valberedningens förslag till ny styrelse inför årsstämman 2015
Board/Management Information Classification · 99% confidence The document is titled 'Valberedningens förslag till ny styrelse inför årsstämman 2015' (The Nomination Committee's proposal for a new board ahead of the 2015 Annual General Meeting). It details the composition of the nomination committee and proposes re-election and new appointments for the Board of Directors. This content directly relates to the governance structure and the election of board members, which falls under the scope of Board/Management Information (MANG) or potentially Governance Information (CGR). Since it specifically concerns the proposal for the board composition ahead of the AGM, MANG is the most precise fit, as it covers 'Announcement of changes in the company's board of directors or senior management.' It is not a full AGM presentation (AGM-R) or a proxy statement (PSI), but rather the announcement of the proposed slate.
2015-02-18 Swedish
Major Shareholding Notification 2015
Major Shareholding Notification Classification · 99% confidence The document explicitly details a change in shareholding for an individual ('Staffan Rasjö') in Medivir Aktiebolag. It shows the 'Before the transaction' and 'After the transaction' share quantities, voting rights, and the resulting percentage, specifically noting the 'Reason for major shareholding notification Sell'. This structure perfectly matches the definition of a Major Shareholding Notification, which reports changes in significant ownership levels crossing thresholds.
2015-02-12 English
Final terms for Medivir’s voluntary redemption programme
Share Issue/Capital Change Classification · 99% confidence The document announces the 'Final terms for Medivir's voluntary redemption programme,' detailing the cash consideration, the ratio of redemption rights to shares, and a precise timeline of dates for the process (e.g., record day, application period, payment date). This action involves a reduction of share capital and repayment to shareholders, which is a significant change to the company's capital structure. This aligns directly with the definition of 'Capital/Financing Update' (CAP), which covers fundraising, financing activities, or capital structure changes. It is not an earnings release (ER), an annual report (10-K), or a simple dividend notice (DIV), but a specific corporate action related to capital restructuring.
2015-01-30 English
Villkoren för frivilligt inlösenprogram i Medivir fastställda
Delisting Announcement Classification · 99% confidence The document announces the finalization of terms for a voluntary share redemption program ('frivilligt inlösenprogram') by Medivir AB. It details the exchange ratio (one share for every seven redemption rights), the cash consideration (140 SEK per share), and provides a detailed timeline of key dates related to the redemption, trading of rights, and final payment. This activity directly concerns changes to the company's capital structure and the return of capital to shareholders. This aligns precisely with the definition of 'Capital/Financing Update' (CAP), which covers fundraising, financing activities, or capital structure changes. Although it involves a share transaction, it is a structured capital return rather than a simple buyback (POS) or a general share issue (SHA). Since it is a definitive announcement of the terms of a capital restructuring event, CAP is the most appropriate classification.
2015-01-30 Swedish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.